Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

INFU stock hub

InfuSystem Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INFUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

169.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

INFU

In the news

Latest news · INFU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.6

P25 12.3P50 18.4P75 33.1

Trailing P/E22.7

P25 14.9P50 23.2P75 38.5

ROE13.9

P25 -105.6P50 -46.5P75 -3.1

ROIC10.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INFU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

254

Groups with data

Currency

USD

Showing 254 of 254 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001337013
Company name	InfuSystem Holdings, Inc.
Country	United States
Country code	US
Cusip	45685K102
Employees	473
Employees Change	-41%
Employees Change Percent	-7.98
Enterprise value	$190.5M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US45685K1025
Last refreshed	2026-05-10
Market cap	$169.8M
Market cap category	Micro-Cap
Price	$8.41
Price currency	USD
Rev Per Employee	301,065.54x
Sector	Healthcare
Sic	3841
Symbol	INFU
Website	https://www.infusystem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.66%
EV Earnings	24.08x
EV Sales Forward	1.24x
EV/EBIT	16.02x
EV/EBITDA	7.61x
EV/FCF	11.55x
EV/Sales	1.34x
FCF yield	9.71%
Forward P/E	16.57x
P/B ratio	2.89x
P/E ratio	22.7x
P/S ratio	1.19x
PE Ratio10 Y	653.64x
PE Ratio3 Y	305.69x
PE Ratio5 Y	923.16x
PEG ratio	0.55x
PS Forward	1.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.35%
EBITDA Margin	17.57%
FCF margin	11.58%
Gross margin	56.75%
Gross Profit	$80.8M
Gross Profit Growth	10.55%
Gross Profit Growth Q	2.69%
Gross Profit Growth3 Y	10.32%
Gross Profit Growth5 Y	6.05%
Net Income	$7.9M
Net Income Growth	147.99%
Net Income Growth Quarters	8%
Net Income Growth Years	3%
Net Income Growth3 Y	403.44%
Net Income Growth5 Y	-15.54%
Pretax Margin	8.28%
Profit Margin	5.56%
Profit Per Employee	$16,725
Profitable Years	7
ROA	7.32
Roa5y	3.32
ROCE	14.59
ROE	13.89
Roe5y	4.16
ROIC	10.1
Roic5y	3.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.78%
Cagr15y	8.11%
Cagr1y	77.12%
Cagr3y	-2.41%
Cagr5y	-16.61%
EPS Growth	148.1
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	748.3
EPS Growth5 Y	-14.88
FCF Growth	620.4%
FCF Growth5 Y	17%
OCF Growth	7.94%
OCF Growth Q	-45.51%
OCF Growth10 Y	10.39%
OCF Growth3 Y	21.1%
OCF Growth5 Y	1.07%
Revenue Growth	3.51x
Revenue Growth Q	-2.97x
Revenue Growth Years	7x
Revenue Growth3 Y	7.83x
Revenue Growth5 Y	7.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.4
Assets	$98.7M
Cash	$2.1M
Current Assets	$36.7M
Current Liabilities	$17.1M
Debt	$22.8M
Debt EBITDA	$0.83
Debt Equity	$0.39
Debt FCF	$1.38
Equity	$58.7M
Interest Coverage	9.76
Liabilities	$39.9M
Long Term Assets	$62M
Long Term Liabilities	$22.8M
Net Cash	$-20.7M
Net Cash By Market Cap	$-12.17
Net Debt EBITDA	$0.83
Net Debt Equity	$0.35
Net Debt FCF	$1.25
Tangible Book Value	$48.4M
Tangible Book Value Per Share	$2.4
WACC	11.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.14
Inventory Turnover	10.33
Net Working Capital	$17.4M
Quick ratio	1.52
Working Capital	$19.5M
Working Capital Turnover	$7.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	154.08%
1Y total return	77.05%
200-day SMA	9.25
3Y total return	-7.07%
50-day SMA	9.74
50-day SMA vs 200-day SMA	50over200
5Y total return	-59.66%
All Time High	23.26
All Time High Change	-63.84%
All Time High Date	2021-03-17
All Time Low	0.75
All Time Low Change	1,021.33%
All Time Low Date	2011-09-26
ATR	0.57
Beta	1.49
Beta1y	1.73
Beta2y	1.69
Ch YTD	-6.24
High	9.03
High52	11.04
High52 Date	2025-08-29
High52ch	-23.82%
Low	8.37
Low52	5.08
Low52 Date	2025-05-28
Low52ch	65.55%
Ma50ch	-13.61%
Premarket Change Percent	0.67
Premarket Price	$9.03
Premarket Volume	3,310
Price vs 200-day SMA	-9.11%
RSI	32.87
RSI Monthly	49.41
RSI Weekly	44.95
Sharpe ratio	1.22x
Sortino ratio	2.2
Total Return	2.96%
Tr YTD	-6.24
Tr15y	222.22%
Tr1m	-10.15%
Tr1w	-18.9%
Tr3m	8.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.04
Earnings Revenue Estimate	34,376,800x
Earnings Revenue Estimate Growth	-0.98x
Operating Income	$11.9M
Operating Income Growth	27.13
Operating Income Growth Q	-1.73
Operating Income Growth3 Y	79.04
Operating Income Growth5 Y	4.23
Operating margin	8.35
Price target	$15
Price Target Change	$78.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,113,623%
Float Percent	94.65%
Net Borrowing	-8,947,000
Shares Insiders	5.35%
Shares Institutions	80.99%
Shares Out	20,193,998
Shares Qo Q	-0.82%
Shares Yo Y	-2.96%
Short Float	1.11%
Short Ratio	2.31
Short Shares	1.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$12M
Average Volume	149,995.9x
Bv Per Share	2.91
CAPEX	$-7.1M
Ch10y	154.1
Ch15y	222.2
Ch1m	-10.15
Ch1w	-18.9
Ch1y	77.05
Ch3m	8.94
Ch3y	-7.07
Ch5y	-59.66
Ch6m	-15.22
Change	-6.24%
Change From Open	-6.87
Close	8.97
Days Gap	0.67
Depreciation Amortization	13,127,000
Dollar Volume	2,920,204.3
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$11.9M
EBITDA	$25M
EPS	$0.37
F Score	7
FCF	$16.5M
FCF EV Yield	8.66x
FCF Per Share	$0.82
Financing CF	-17,609,000
Fiscal Year End	December
Founded	2,005
Goodwill	3,710,000
Graham Number	4.92679
Graham Upside	-41.42
Income Tax	$3.9M
Investing CF	-5,389,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Lynch Fair Value	$1.85
Lynch Upside	-77.97
Ma150	9.29
Ma150ch	-9.43%
Ma20	10.13
Ma20ch	-16.95%
Net CF	600,000
Next Earnings Date	2026-08-04
Open	9.03
Optionable	Yes
P FCF Ratio	10.3
P OCF Ratio	7.2
Position In Range	6.06
Ppne	41,316,000
Pre Close	8.97
Price Date	2026-05-08
Price EBITDA	$6.79
Ptbv Ratio	3.51
Relative Volume	2.31x
Revenue	142,404,000x
SBC By Revenue	3.15x
Share Based Comp	4,488,000
Tax By Revenue	2.72x
Tax Rate	32.88%
Tr6m	-15.22%
Us State	Michigan
Volume	347,230

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INFU pay a dividend?

Capital-return profile for this ticker.

Performance

INFU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INFU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.0%

Float: +94.7% of shares outstanding

Insider ownership

+5.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INFU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.9

Neutral momentum band

Price vs 200-day MA

-9.1%

50/200-day relationship not available

Beta (5Y)

1.49

More volatile than the market

Sharpe ratio

1.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INFU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INFU stock rating?

InfuSystem Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INFU analysis?

The full report lives at /stocks/INFU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INFU?

The latest report frames INFU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INFU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.